310 related articles for article (PubMed ID: 21836478)
21. Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems.
Walts AE; Hiroshima K; Marchevsky AM
Ann Diagn Pathol; 2015 Aug; 19(4):216-20. PubMed ID: 25979154
[TBL] [Abstract][Full Text] [Related]
22. Value of PAX 8 immunostaining in tumor diagnosis: a review and update.
Ordóñez NG
Adv Anat Pathol; 2012 May; 19(3):140-51. PubMed ID: 22498579
[TBL] [Abstract][Full Text] [Related]
23. Detection of bcl-2 and p53 in thymoma: expression of bcl-2 as a reliable marker of tumor aggressiveness.
Chen FF; Yan JJ; Jin YT; Su IJ
Hum Pathol; 1996 Oct; 27(10):1089-92. PubMed ID: 8892596
[TBL] [Abstract][Full Text] [Related]
24. Expression of PD-1 and PD-L1 in thymic epithelial neoplasms.
Weissferdt A; Fujimoto J; Kalhor N; Rodriguez J; Bassett R; Wistuba II; Moran CA
Mod Pathol; 2017 Jun; 30(6):826-833. PubMed ID: 28281549
[TBL] [Abstract][Full Text] [Related]
25. PAX2 and PAX8: useful markers for metastatic effusions.
Waters L; Crumley S; Truong L; Mody D; Coffey D
Acta Cytol; 2014; 58(1):60-6. PubMed ID: 24334997
[TBL] [Abstract][Full Text] [Related]
26. Expression of cathepsins V and S in thymic epithelial tumors.
Kiuchi S; Tomaru U; Ishizu A; Imagawa M; Kiuchi T; Iwasaki S; Suzuki A; Otsuka N; Deguchi T; Shimizu T; Marukawa K; Matsuno Y; Kasahara M
Hum Pathol; 2017 Feb; 60():66-74. PubMed ID: 27771373
[TBL] [Abstract][Full Text] [Related]
27. Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis?
Jeong YJ; Lee KS; Kim J; Shim YM; Han J; Kwon OJ
AJR Am J Roentgenol; 2004 Aug; 183(2):283-9. PubMed ID: 15269013
[TBL] [Abstract][Full Text] [Related]
28. [Thymomas and thymic carcinomas].
De Montpréville VT
Rev Mal Respir; 2010 Dec; 27(10):1281-7. PubMed ID: 21163404
[No Abstract] [Full Text] [Related]
29. PAX1 expression in thymic epithelial neoplasms and morphologic mimics.
Parrack PH; Hornick JL; Sholl LM
Hum Pathol; 2023 Dec; 142():7-14. PubMed ID: 37776957
[TBL] [Abstract][Full Text] [Related]
30. Tyrosine kinase receptor expression in thymomas.
Henley JD; Cummings OW; Loehrer PJ
J Cancer Res Clin Oncol; 2004 Apr; 130(4):222-4. PubMed ID: 14762710
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms.
Nonaka D; Henley JD; Chiriboga L; Yee H
Am J Surg Pathol; 2007 Jul; 31(7):1038-44. PubMed ID: 17592270
[TBL] [Abstract][Full Text] [Related]
32. Pax8: a marker for carcinoma of Müllerian origin in serous effusions.
Tong GX; Devaraj K; Hamele-Bena D; Yu WM; Turk A; Chen X; Wright JD; Greenebaum E
Diagn Cytopathol; 2011 Aug; 39(8):567-74. PubMed ID: 20607683
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
Ye J; Hameed O; Findeis-Hosey JJ; Fan L; Li F; McMahon LA; Yang Q; Wang HL; Xu H
Biotech Histochem; 2012 Jan; 87(1):30-4. PubMed ID: 21838611
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of PAX8 Expression and Its Potential Diagnostic and Prognostic Value in Renal and Extra-Renal Ewing Sarcomas/PNETs.
Markow M; Bui MM; Lin HY; Lloyd M; Sexton WJ; Dhillon J
Pathol Oncol Res; 2016 Jan; 22(1):115-20. PubMed ID: 26350056
[TBL] [Abstract][Full Text] [Related]
35. Prediction of thymoma histology and stage by radiographic criteria.
Yanagawa M; Tomiyama N
Thorac Surg Clin; 2011 Feb; 21(1):1-12, v. PubMed ID: 21070982
[TBL] [Abstract][Full Text] [Related]
36. Thymic epithelial neoplasms with sebaceous differentiation: a clinicopathological and immunohistochemical study of 8 cases.
Kalhor N; Moran CA
Hum Pathol; 2019 Apr; 86():124-128. PubMed ID: 30537491
[TBL] [Abstract][Full Text] [Related]
37. Utility of PAX8 mouse monoclonal antibody in the diagnosis of thyroid, thymic, pleural and lung tumours: a comparison with polyclonal PAX8 antibody.
Toriyama A; Mori T; Sekine S; Yoshida A; Hino O; Tsuta K
Histopathology; 2014 Oct; 65(4):465-72. PubMed ID: 24592933
[TBL] [Abstract][Full Text] [Related]
38. Corpuscular thymoma: entity or variant of organotypical thymomas WHO B2/B3?
Laeng RH; Eimoto T; Kuo TT; Zettl A; Marx A; Moschopulos M; Tateyama H; Shimokawa K
Pathol Res Pract; 2006; 202(10):697-704. PubMed ID: 16887284
[TBL] [Abstract][Full Text] [Related]
39. Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study.
Tacha D; Zhou D; Cheng L
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):293-9. PubMed ID: 21285870
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of PAX2 and PAX8 expression in salivary gland neoplasms.
Butler RT; Alderman MA; Thompson LD; McHugh JB
Head Neck Pathol; 2015 Mar; 9(1):47-50. PubMed ID: 24771139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
